| User's Publication |
|
22091
Kume K, Iida M, Iwaya T, Yashima-Abo A, Koizumi Y, Endo A, Wade K, Hiraki H, Calvert V, Wulfkuhle J, Espina V, Siwak DR, Lu Y, Takemoto K, Suzuki Y, Sasaki Y, Tokino T, Petricoin E 3rd, Liotta LA, Mills GB, Nishizuka SS.
Targeted dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit.
Mol Cell Proteomics
2024
100870
PubMed ID: 39461475
DOI: 10.1016/j.mcpro.2024.100870
|
|
19553
Fujino H, Sonoda-Fukuda E, Isoda L, Kawabe A, Takarada T, Kasahara N, Kubo S.
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
Int J Mol Sci
2023
24(19):14823
PubMed ID: 37834271
DOI: 10.3390/ijms241914823
|
|
19687
Mori Y, Nishikawa SG, Fratiloiu AR, Tsutsui M, Kataoka H, Joh T, Johnston RN.
Modulation of Reoviral Cytolysis (I): Combination Therapeutics
Viruses
2023
15(7):1472
PubMed ID: 37515160
DOI: 10.3390/v15071472
|
|
19939
hiozaki A, Fukami T, Shimizu H, Kosuga T, Kudou M, Takemoto K, Katsurahara K, Nishibeppu K, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Otsuji E.
Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer
Ann Surg Oncol
2023
30(13):8704-8716
PubMed ID: 37599296
DOI: 10.1245/s10434-023-14084-0
|
|
19972
Eom JW, Lim JW, Kim H.
Lutein Induces Reactive Oxygen Species-Mediated Apoptosis in Gastric Cancer AGS Cells via NADPH Oxidase Activation
Molecules
2023
28(3):1178
PubMed ID: 36770846
DOI: 10.3390/molecules28031178
|
|
21477
Takeuchi C, Sato J, Yamamichi N, Kageyama-Yahara N, Sasaki A, Akahane T, Aoki R, Nakajima S, Ito M, Yamamichi M, Liu YY, Sakuma N, Takahashi Y, Sakaguchi Y, Tsuji Y, Sakurai K, Tomida S, Niimi K, Ushijima T, Fujishiro M.
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
J Gastroenterol
2023
PubMed ID: 37962678
DOI: 10.1007/s00535-023-02055-x
|
|
17567
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Kamiya H, Shimizu H, Arita T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
Cancer Sci
2022
113(6):1984-1998
PubMed ID: 35307915
DOI: 10.1111/cas.15342
|
|
18233
Zhang W, Auguste A, Liao X, Walterskirchen C, Bauer K, Lin YH, Yang L, Sayedian F, Fabits M, Bergmann M, Binder C, Corrales L, Vogt AB, Hudson LJ, Barnes MP, Bisht A, Giragossian C, Voynov V, Adam PJ, Hipp S.
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors
Clin Cancer Res
2022
28(23):5190-5201
PubMed ID: 36166004
DOI: 10.1158/1078-0432.CCR-22-2108
|
|
18828
Iwamuro M, Shiraha H, Kobashi M, Horiguchi S, Okada H.
Laminin 511-E8 Fragment Offers Superior Adhesion Properties for Gastric Cancer Cells Compared with Full-Length Laminin 511
Curr Issues Mol Biol
2022
44(4):1539-1551
PubMed ID: 35723363
DOI: 10.3390/cimb44040105
|
|
20459
Kato S, Shiozaki A, Kudou M, Shimizu H, Kosuga T, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
TRPV2 Promotes Cell Migration and Invasion in Gastric Cancer via the Transforming Growth Factor-β Signaling Pathway.
Ann Surg Oncol
2022
PubMed ID: 34855064
DOI: 10.1245/s10434-021-11132-5
|
|
20478
Xu J, Zhou Y, Yang J, Gu Y, Zhang E, Yuan W, Wang C, Jin G, Ma H, Hu Z.
Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
Gene
2022
146115
PubMed ID: 34902508
DOI: 10.1016/j.gene.2021.146115
|
|
16170
Yoshioka H, Kawamura T, Muroi M, Kondoh Y, Honda K, Kawatani M, Aono H, Waldmann H, Watanabe N, Osada H.
Identification of a Small Molecule That Enhances Ferroptosis via Inhibition of Ferroptosis Suppressor Protein 1 (FSP1)
ACS Chem Biol
2022
Feb 7.
PubMed ID: 35128925
DOI: 10.1021/acschembio.2c00028
|
|
20622
Takaki W, Konishi H, Matsubara D, Shoda K, Arita T, Kataoka S, Shibamoto J, Furuke H, Takabatake K, Shimizu H, Komatsu S, Shiozaki A, Kubota T, Okamoto K, Otsuji E.
Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer.
Int J Mol Sci
2022
23(6)
PubMed ID: 35328684
DOI: 10.3390/ijms23063264
|
|
20625
Ishikawa A, Kuraoka K, Zaitsu J, Saito A, Kuwai T, Tazawa H, Suzuki T, Tashiro H, Taniyama K, Yasui W.
Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells.
Anticancer Res
2022
42(4):1707-1717
PubMed ID: 35346989
DOI: 10.21873/anticanres.15647
|
|
20627
Soda T, Gen Y, Terasaki K, Iwai N, Kitaichi T, Dohi O, Taketani H, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Konishi H, Naito Y, Itoh Y, Yasui K.
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.
Sci Rep
2022
12(1):5050
PubMed ID: 35322078
DOI: 10.1038/s41598-022-08904-8
|
|
20661
Inoue H, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
Functions and Clinical Significance of CACNA2D1 in Gastric Cancer.
Ann Surg Oncol
2022
PubMed ID: 35445337
DOI: 10.1245/s10434-022-11752-5
|
|
16979
Ma J, Zhang C, Liang W, Li L, Du J, Pan C, Chen B, Chen Y, Wang Y.
ω-3 and ω-6 Polyunsaturated Fatty Acids Regulate the Proliferation, Invasion and Angiogenesis of Gastric Cancer Through COX/PGE Signaling Pathway
Front Oncol
2022
12:802009
PubMed ID: 35251974
DOI: 10.3389/fonc.2022.802009
|
|
20953
Sugezawa K, Morimoto M, Yamamoto M, Matsumi Y, Nakayama Y, Hara K, Uejima C, Kihara K, Matsunaga T, Tokuyasu N, Sakamoto T, Umekita Y, Fujiwara Y.
GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer.
Anticancer Res
2022
42(12):5719-5729
PubMed ID: 36456115
DOI: 10.21873/anticanres.16079
|
|
21996
Fukami T, Shiozaki A, Kosuga T, Kudou M, Shimizu H, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Morinaga Y, Konishi E, Otsuji E.
Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer
World J Gastroenterol
2022
28(32):4649-4667.
PubMed ID: 36157935
DOI: 10.3748/wjg.v28.i32.4649
|
|
18099
Kato T, Nakamori M, Matsumura S, Nakamura M, Ojima T, Fukuhara H, Ino Y, Todo T, Yamaue H.
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Oncol Lett
2021
21(6):490
PubMed ID: 33968206
DOI: 10.3892/ol.2021.12751
|
|
13160
Sakuratani T, Takeuchi T, Yasufuku I, Iwata Y, Saigo C, Kito Y, Yoshida K.
Downregulation of ARID1A in gastric cancer cells: a putative protective molecular mechanism against the Harakiri-mediated apoptosis pathway.
Virchows Arch
2021
478(3):401-411
PubMed ID: 32789692
DOI: 10.1007/s00428-020-02899-1
|
|
13323
Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
J Cancer
2021
PubMed ID: 33391428
DOI: 10.7150/jca.47577
|
|
13337
Kim S, Ahn JM, Bae WJ, Han JH, Lee D.
Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer.
Gastric Cancer
2021
24(3):577-588
PubMed ID: 33164142
DOI: 10.1007/s10120-020-01139-4
|
|
13414
Yuza K, Nagahashi M, Ichikawa H, Hanyu T, Nakajima M, Shimada Y, Ishikawa T, Sakata J, Takeuchi S, Okuda S, Matsuda Y, Abe M, Sakimura K, Takabe K, Wakai T.
Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer.
J Gastrointest Surg
2021
PubMed ID: 33420656
DOI: 10.1007/s11605-020-04889-9
|
|
20005
Iwata Y, Yasufuku I, Saigo C, Kito Y, Takeuchi T, Yoshida K.
Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.
J Cancer
2021
12(4):1161-1168
PubMed ID: 33442414
DOI: 10.7150/jca.46765
|
|
20061
Iwamuro M, Shiraha H, Oyama A, Uchida D, Horiguchi S, Okada H.
Laminin-411 and -511 Modulate the Proliferation, Adhesion, and Morphology of Gastric Cancer Cells.
Cell Biochem Biophys
2021
PubMed ID: 33629255
DOI: 10.1007/s12013-021-00972-3
|
|
20098
Tsuji T, Maeda Y, Kita K, Murakami K, Saya H, Takemura H, Inaki N, Oshima M, Oshima H.
FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
Oncogene
2021
PubMed ID: 33795838
DOI: 10.1038/s41388-021-01757-x
|
|
20116
Kurashima K, Shiozaki A, Kudou M, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway.
Gastric Cancer
2021
PubMed ID: 33864161
DOI: 10.1007/s10120-021-01187-4
|
|
20148
Kubo H, Murayama Y, Ogawa S, Matsumoto T, Yubakami M, Ohashi T, Kubota T, Okamoto K, Kamiya M, Urano Y, Otsuji E.
β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer.
Sci Rep
2021
11(1):10664
PubMed ID: 34021168
DOI: 10.1038/s41598-021-88982-2
|
|
14345
Katsurahara K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer
Cancer Sci
2021
112(3):1026-1037.
PubMed ID: 33404124
DOI: 10.1111/cas.14796
|
|
14347
Matsumura S, Nakamori M, Tsuji T, Kato T, Nakamura M, Ojima T, Fukuhara H, Ino Y, Todo T, Yamaue H.
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
Oncotarget
2021
12(4):344-354
PubMed ID: 33659045
DOI: 10.18632/oncotarget.27873
|
|
20224
Ogawa S, Kubo H, Murayama Y, Kubota T, Yubakami M, Matsumoto T, Ohashi T, Okamoto K, Kuriki Y, Hanaoka K, Urano Y, Otsuji E.
Matrix metalloprotease-14 is a Target Enzyme for Detecting Peritoneal Metastasis in Gastric Cancer.
Photodiagnosis Photodyn Ther
2021
PubMed ID: 34242818
DOI: 10.1016/j.pdpdt.2021.102420
|
|
20324
Abe H, Kunita A, Otake Y, Kanda T, Kaneda A, Ushiku T, Fukayama M.
Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
PLoS One
2021
16(9):e0256440
PubMed ID: 34469459
DOI: 10.1371/journal.pone.0256440
|
|
20358
Zhang J, Wang F, Zhang H, Cao M.
A novel circular RNA circ_HN1/miR-628-5p/Ecto-5'-nucleotidase competing endogenous RNA network regulates gastric cancer development.
Bioengineered
2021
PubMed ID: 34637682
DOI: 10.1080/21655979.2021.1989259
|
|
20385
Ito K, Kitajima Y, Kai K, Matsufuji S, Yamada K, Egawa N, Kitagawa H, Okuyama K, Tanaka T, Noshiro H.
Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.
Int J Oncol
2021
59(6)
PubMed ID: 34738626
DOI: 10.3892/ijo.2021.5282
|
|
20421
Reyna-Jeldes M, De la Fuente-Ortega E, Cerda D, Velázquez-Miranda E, Pinto K, Vázquez-Cuevas FG, Coddou C.
Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines.
Pharmaceutics
2021
13(8)
PubMed ID: 34452195
DOI: 10.3390/pharmaceutics13081234
|
|
16126
Nakamura K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
The expression of the alpha1 subunit of Na +/K +-ATPase is related to tumor development and clinical outcomes in gastric cancer
Gastric Cancer
2021
24(6):1278-1292
PubMed ID: 34251542
DOI: 10.1007/s10120-021-01212-6
|
|
16522
Kawatani M, Aono H, Hiranuma S, Shimizu T, Muroi M, Ogawa N, Ohishi T, Ohba SI, Kawada M, Nogawa T, Okano A, Hashizume D, Osada H.
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth
ACS Chem Biol
2021
16(8):1576-1586
PubMed ID: 34296611
DOI: 10.1021/acschembio.1c00480
|
|
16803
Egawa N, Tanaka T, Matsufuji S, Yamada K, Ito K, Kitagawa H, Okuyama K, Kitajima Y, Noshiro H.
Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells
FEBS Open Bio
2021
11(5):1465-1475
PubMed ID: 33773069
DOI: 10.1002/2211-5463.13154
|
|
16896
Shiozaki A, Katsurahara K, Kudou M, Shimizu H, Kosuga T, Ito H, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Otsuji E.
Amlodipine and Verapamil, Voltage-Gated Ca 2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells
Ann Surg Oncol
2021
28(9):5400-5411
PubMed ID: 33566246
DOI: 10.1245/s10434-021-09645-0
|
|
11815
Nakade H, Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Miyao S, Sho M.
Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Int. J. Clin. Oncol.
2020
25(3):446-455
PubMed ID: 31535245
DOI: 10.1007/s10147-019-01547-2
|
|
12041
Hirano T, Shinsato Y, Tanabe K, Higa N, Kamil M, Kawahara K, Yamamoto M, Minami K, Shimokawa M, Arigami T, Yanagita S, Matushita D, Uenosono Y, Ishigami S, Kijima Y, Maemura K, Kitazono I, Tanimoto A, Furukawa T, Natsugoe S.
FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer.
Oncogenesis
2020
PubMed ID: 32029704
DOI: 10.1038/s41389-020-0190-7
|
|
13242
Uejima C, Morimoto M, Yamamoto M, Hara K, Miyauchi W, Sugezawa K, Tada Y, Tanio A, Kihara K, Matsunaga T, Tokuyasu N, Sakamoto T, Honjo S, Umekita Y, Fujiwara Y.
Prognostic Significance of TYRO3 Receptor Tyrosine Kinase Expression in Gastric Cancer.
Anticancer Res
2020
40(10):5593-5600
PubMed ID: 32988883
DOI: 10.21873/anticanres.14572
|
|
13344
Hinata M, Kunita A, Abe H, Morishita Y, Sakuma K, Yamashita H, Seto Y, Ushiku T, Fukayama M.
Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation.
Microorganisms
2020
PubMed ID: 33198173
DOI: 10.3390/microorganisms8111776
|
|
13504
Baatar S, Bai T, Yokobori T, Gombodorj N, Nakazawa N, Ubukata Y, Kimura A, Kogure N, Sano A, Sohda M, Sakai M, Tumenjargal A, Ogata K, Kuwano H, Shirabe K, Saeki H.
High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer
Ann Surg Oncol
2020
27(11):4360-4368
PubMed ID: 32356270
DOI: 10.1245/s10434-020-08518-2
|
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
|
13626
Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, Miyao S, Sho M.
RNF126 as a Marker of Prognosis and Proliferation of Gastric Cancer
Anticancer Res
2020
40(3):1367-1374
PubMed ID: 32132033
DOI: 10.21873/anticanres.14078
|
|
13838
He J, Ge Q, Lin Z, Shen W, Lin R, Wu J, Wang B, Lu Y, Chen L, Liu X, Zheng W, Zhang Y, Wang L, Wang K, Wang L, Zhuo W, Chen S.
MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression
FASEB J
2020
34(6):8544-8557
PubMed ID: 32356314
DOI: 10.1096/fj.201903217R
|
|
19269
Shun Zhang, Yoshinori Kohira, Hajime Orita, Momoko Ishimine, Toshiyuki Kobayashi, Sharlyn Mae Buendia Chua, Hirofumi Nakaoka, Ituro Inoue, Okio Hino, Takehiko Yokomizo, Tetsu Fukunaga, Hyeon-Cheol Lee-Okada
Sensitization of Gastric Cancer Cells to Irinotecan by p53 Activation
BPB Reports
2019
2:130-133
DOI: 10.1248/bpbreports.2.6_130
|
|
11202
Shiozaki A, Ariyoshi Y, Iitaka D, Kosuga T, Shimizu H, Kudou M, Konishi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Ichikawa D, Otsuji E.
Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.
Gastric Cancer
2019
PubMed ID: 30191346
DOI: 10.1007/s10120-018-0874-2
|
|
6418
Hevia MJ, Castro P, Pinto K1, Reyna-Jeldes M, Rodríguez-Tirado F, Robles-Planells C, Ramírez-Rivera S, Madariaga JA, Gutierrez F, López J, Barra M, De la Fuente-Ortega E, Bernal G, Coddou C.
Differential Effects of Purinergic Signaling in Gastric Cancer-Derived Cells Through P2Y and P2X Receptors.
Front Pharmacol
2019
10:612
PubMed ID: 31249523
DOI: 10.3389/fphar.2019.00612
|
|
11641
Morito K, Shimizu R, Kitamura N, Park SB, Kishino S, Ogawa J, Fukuta T, Kogure K, Tanaka T.
Gut microbial metabolites of linoleic acid are metabolized by accelerated peroxisomal β-oxidation in mammalian cells.
Biochim Biophys Acta Mol Cell Biol Lipids
2019
PubMed ID: 31351225
DOI: 10.1016/j.bbalip.2019.07.010
|
|
11499
S Zhang et al
Sensitization of Gastric Cancer Cells to Irinotecan by p53 Activation
BPB Reports
2019
2,130-133
|
|
10787
Shimada S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, Kagechika H, Nagasaki H, Fukamachi H, Yuasa Y, Tanaka S.
Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
Br. J. Cancer
2018
118:972-984
PubMed ID: 29527007
DOI: 10.1038/s41416-018-0008-y
|
|
10796
Matsuoka K, Nakagawa F, Kobunai T, Takechi T.
Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.
Oncotarget
2018
9:13438-13450
PubMed ID: 29568368
DOI: 10.18632/oncotarget.24412
|
|
11095
Kim M, Pyo S, Kang CH, Lee CO, Lee HK, Choi SU, Park CH.
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
PLoS ONE
2018
13(6):e0198347
PubMed ID: 29874279
DOI: 10.1371/journal.pone.0198347
|
|
11219
Kato R, Iwamuro M, Shiraha H, Horiguchi S, Tanaka E, Matsumoto K, Ohyama A, Sawahara H, Nagahara T, Uchida D, Tsutsumi K, Okada H.
Dipeptide γ-secretase inhibitor treatment enhances the anti-tumor effects of cisplatin against gastric cancer by suppressing cancer stem cell properties.
Oncol Lett
2018
PubMed ID: 30250614
DOI: 10.3892/ol.2018.9301
|
|
11231
Wang Z, Qu H, Gong W, Liu A.
Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
IUBMB Life
2018
PubMed ID: 30281914
DOI: 10.1002/iub.1934
|
|
4299
Yoshida J, Abe H, Watanabe T, Kawada M.
Intervenolin suppresses gastric cancer cell growth through the induction of TSP-1 secretion from fibroblast-like stromal cells.
Oncol Lett
2018
PubMed ID: 30405822
DOI: 10.3892/ol.2018.9485
|
|
4303
Afroz S, Yagi A, Fujikawa K, Rahman MM, Morito K, Fukuta T, Watanabe S, Kiyokage E, Toida K, Shimizu T, Ishida T, Kogure K, Tokumura A, Tanaka T.
Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro.
Prostaglandins Other Lipid Mediat.
2018
PubMed ID: 29462674
DOI: 10.1016/j.prostaglandins.2018.01.003
|
|
4304
Zhang N, Xu J, Wang Y, Heng X, Yang L, Xing X.
Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
Oncol Lett
2018
PubMed ID: 29805691
DOI: 10.3892/ol.2018.8562
|
|
13126
Gaowa S, Futamura M, Tsuneki M, Kamino H, Tajima JY, Mori R, Arakawa H, Yoshida K.
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Cancer Sci
2018
PubMed ID: 30290054
DOI: 10.1111/cas.13824
|
|
14733
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma
Carcinogenesis
2018
39(2):263-271
PubMed ID: 29228320
DOI: 10.1093/carcin/bgx139
|
|
14901
Enjoji S, Yabe R, Tsuji S, Yoshimura K, Kawasaki H, Sakurai M, Sakai Y, Takenouchi H, Yoshino S, Hazama S, Nagano H, Oshima H, Oshima M, Vitek MP, Matsuura T, Hippo Y, Usui T, Ohama T, Sato K.
Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
Mol Cancer Res
2018
16(3):554-563
PubMed ID: 29330298
DOI: 10.1158/1541-7786.MCR-17-0393
|
|
9788
Deguchi Y, Okabe H, Oshima N, Hisamori S, Minamiguchi S, Muto M, Sakai Y.
PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.
Gastric Cancer
2017
20:416-427
PubMed ID: 27517839
DOI: 10.1007/s10120-016-0627-z
|
|
10177
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
Introduction of plasmids into gastric cancer cells by endoscopic ultrasound.
Oncol Lett
2017
13:3127-3130
PubMed ID: 28521417
DOI: 10.3892/ol.2017.5836
|
|
10253
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells.
Oncol Lett
2017
13:4322-4326
PubMed ID: 28599433
DOI: 10.3892/ol.2017.5987
|
|
10258
Gen Y, Yasui K, Kitaichi T, Iwai N, Terasaki K, Dohi O, Hashimoto H, Fukui H, Inada Y, Fukui A, Jo M, Moriguchi M, Nishikawa T, Umemura A, Yamaguchi K, Konishi H, Naito Y, Itoh Y.
ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Cancer Lett.
2017
398:52-61
PubMed ID: 28400336
DOI: 10.1016/j.canlet.2017.04.002
|
|
10437
Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.
Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.
Oncol. Rep.
2017
38:1500-1506
PubMed ID: 28731175
DOI: 10.3892/or.2017.5844
|
|
10586
Ishii S, Yamashita K, Harada H, Ushiku H, Tanaka T, Nishizawa N, Yokoi K, Washio M, Ema A, Mieno H, Moriya H, Hosoda K, Waraya M, Katoh H, Watanabe M.
The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.
Oncotarget
2017
8:74567-74581
PubMed ID: 29088808
DOI: 10.18632/oncotarget.20209
|
|
10686
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E.
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
Oncotarget
2017
8:106538-106550
PubMed ID: 29290969
DOI: 10.18632/oncotarget.20860
|
|
4426
Biological activity of intervenolin analogs with a phenyl substituent
The Journal of Antibiotics
2017
71, 86–90
PubMed ID: 29018268
DOI: 10.1038/ja.2017.123
|
|
5806
Shiroki T et al
Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Cancer Sci
2017
108(5):931-940
PubMed ID: 28235245
DOI: 10.1111/cas.13211
|
|
13680
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine
Oncol Lett
2017
13(3):1276-1280
PubMed ID: 28454246
DOI: 10.3892/ol.2017.5568
|
|
14242
Wakiyama K, Kitajima Y, Tanaka T, Kaneki M, Yanagihara K, Aishima S, Nakamura J, Noshiro H.
Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis
Sci Rep
2017
7(1):12653
PubMed ID: 28978999
DOI: 10.1038/s41598-017-12929-9
|
|
14615
Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Oncotarget
2017
8(64):107666-107677
PubMed ID: 29296196
DOI: 10.18632/oncotarget.22587
|
|
14735
Ishida K, Ito C, Ohmori Y, Kume K, Sato KA, Koizumi Y, Konta A, Iwaya T, Nukatsuka M, Kobunai T, Takechi T, Nishizuka SS.
Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil
Sci Rep
2017
7(1):2262
PubMed ID: 28536445
DOI: 10.1038/s41598-017-02548-9
|
|
14737
Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, Okuyama K, Kitagawa H, Tanaka T, Hiraki M, Yanagihara K, Noshiro H.
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines
Sci Rep
2017
7(1):11127
PubMed ID: 28894280
DOI: 10.1038/s41598-017-11769-x
|
|
14746
Chen Z, Hu T, Zhu S, Mukaisho K, El-Rifai W, Peng DF.
Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer
Oncotarget
2017
8(33):54345-54356
PubMed ID: 28903346
DOI: 10.18632/oncotarget.17527
|
|
9573
Maeda Y, Echizen K, Oshima H, Yu L, Sakulsak N, Hirose O, Yamada Y, Taniguchi T, Jenkins BJ, Saya H, Oshima M.
Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
Cancer Prev Res (Phila)
2016
9:253-63
PubMed ID: 26888865
DOI: 10.1158/1940-6207.CAPR-15-0315
|
|
9610
Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M.
Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.
Nat Microbiol
2016
1:16026
PubMed ID: 27572445
DOI: 10.1038/nmicrobiol.2016.26
|
|
9678
Kayamori K, Katsube K, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, Ohata Y, Akashi T, Saitoh M, Harada K, Harada H, Yamaguchi A.
NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma.
PLoS ONE
2016
11:e0154112
PubMed ID: 27124156
DOI: 10.1371/journal.pone.0154112
|
|
9679
Narukawa Y, Komatsu C, Yamauchi R, Shibayama S, Hachisuka M, Kiuchi F.
Two new lignans and melanogenesis inhibitors from Schisandra nigra.
J Nat Med
2016
70:460-6
PubMed ID: 27142263
DOI: 10.1007/s11418-016-1000-6
|
|
9681
Widyowati R, Sugimoto S, Yamano Y, Sukardiman , Otsuka H, Matsunami K.
New Isolinariins C, D and E, Flavonoid Glycosides from Linaria japonica.
Chem. Pharm. Bull.
2016
64:517-21
PubMed ID: 27150486
DOI: 10.1248/cpb.c16-00073
|
|
9684
Isono T, Chano T, Yonese J, Yuasa T.
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas.
Sci Rep
2016
6:25669
PubMed ID: 27157976
DOI: 10.1038/srep25669
|
|
9685
Gao J, Fu S, Zeng Z, Li F, Niu Q, Jing D, Feng X.
Cyclic stretch promotes osteogenesis-related gene expression in osteoblast-like cells through a cofilin-associated mechanism.
Mol Med Rep
2016
14:218-24
PubMed ID: 27177232
DOI: 10.3892/mmr.2016.5239
|
|
3733
Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Oncotarget
2016
7(41):67251-67265
PubMed ID: 27572307
DOI: 10.18632/oncotarget.11625
|
|
5811
Maejima R et al
Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Int J Oncol
2016
49(3):887-94
PubMed ID: 27572291
DOI: 10.3892/ijo.2016.3593
|
|
12639
Yamashita K, Kuno A, Matsuda A, Ikehata Y, Katada N, Hirabayashi J, Narimatsu H, Watanabe M.
Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer
Gastric Cancer
2016
19(2):531-54
PubMed ID: 25840959
DOI: 10.1007/s10120-015-0491-2
|
|
12874
Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, Suzuki M, Ogata K, Asao T, Nishiyama M, Oyama T, Kuwano H.
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
Gastric Cancer
2016
19(3):789-97.
PubMed ID: 26472729
DOI: 10.1007/s10120-015-0551-7
|
|
12913
Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Ogino S, Fujita Y, Hiramoto H, Hamada J, Shoda K, Kosuga T, Fujiwara H, Okamoto K, Otsuji E.
Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells
Oncotarget
2016
7(35):56855-56863
PubMed ID: 27487135
DOI: 10.18632/oncotarget.10869
|
|
12951
Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H.
Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer
Oncol Lett
2016
11(2):1026-1034.
PubMed ID: 26893686
DOI: 10.3892/ol.2015.4011
|
|
12968
Kimura A, Ogata K, Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Yanoma T, Suzuki M, Bai T, Oyama T, Kuwano H.
Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer
Oncotarget
2016
7(14):18415-23
PubMed ID: 26943774
DOI: 10.18632/oncotarget.7821
|
|
14146
B Rupavani, V Peesapati, V G M Naiduc & S Ramakrishnad
Synthesis of some new physiologically active polyheterocycles derived from benzocyclohepten-5-ones
Indian Journal of Chemistry
2016
55B:88-93
|
|
7097
Otsuka S, Matsumoto K, Nakajima M, Tanaka T, Ogura S.
Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia.
PLoS ONE
2015
10:e0146026
PubMed ID: 26717566
DOI: 10.1371/journal.pone.0146026
|
|
7255
Nukatsuka M, Nakagawa F, Takechi T.
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Anticancer Res.
2015
35:4605-15
PubMed ID: 26254349
|
|
7512
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA.
Int. J. Oncol.
2015
46:1018-24
PubMed ID: 25586465
DOI: 10.3892/ijo.2015.2830
|
|
5816
Xianqiang Liu, Meili Sun, Shui Yu, Kai Liu, Xirui Li, and Huan Shi
Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells
Onco Targets Ther
2015
8:3095–3104
PubMed ID: 26543378
DOI: 10.2147/OTT.S91122
|
|
5819
Yoshida K, Tsujimoto H, Matsumura K, Kinoshita M, Takahata R, Matsumoto Y, Hiraki S, Ono S, Seki S, Yamamoto J, Hase K.
CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
Cancer Med
2015
4(9):1322-33
PubMed ID: 26077800
DOI: 10.1002/cam4.478
|
|
6064
Tanaka T et al
The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
PLoS One
2015
10(9):e0137257
PubMed ID: 26339797
DOI: 10.1371/journal.pone.0137257
|
|
13701
Fujimoto D, Ueda Y, Hirono Y, Goi T, Yamaguchi A.
PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
Oncotarget
2015
6(33):34788-99
PubMed ID: 26431277
DOI: 10.18632/oncotarget.5858
|
|
14977
Suenaga M, Yamada S, Fuchs BC, Fujii T, Kanda M, Tanaka C, Kobayashi D, Fujiwara M, Tanabe KK, Kodera Y.
CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence
J Surg Oncol
2015
112(6):622-8
PubMed ID: 26416034
DOI: 10.1002/jso.24056
|
|
15000
Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S.
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
PLoS One
2015
10(12):e0145630
PubMed ID: 26695186
DOI: 10.1371/journal.pone.0145630
|
|
15037
Toiyama Y, Tanaka K, Kitajima T, Shimura T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, Ohi M, Inoue Y, Mohri Y, Goel A, Kusunoki M.
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients
Carcinogenesis
2015
36(12):1474-83
PubMed ID: 26420253
DOI: 10.1093/carcin/bgv139
|
|
18949
Murai T, Yamada S, Fuchs BC, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK, Kodera Y.
Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer
J Surg Oncol
2014
109(7):684-9
PubMed ID: 24453058
DOI: 10.1002/jso.23564
|
|
5827
Ito T, Kajino K, Abe M, Sato K, Maekawa H, Sakurada M, Orita H, Wada R, Kajiyama Y, Hino O.
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
Oncol Rep
2014
31(1):27-33
PubMed ID: 24146039
DOI: 10.3892/or.2013.2803
|
|
5829
Tanaka T, Ohmoto M, Morito K, Kondo H, Urikura M, Satouchi K, Tokumura A.
Type 2 lysophosphatidic acid receptor in gastric surface mucous cells: Possible implication of prostaglandin E2 production.
Biofactors
2014
40(3):355-61
PubMed ID: 24375908
DOI: 10.1002/biof.1147
|
|
12542
Suzuki R, Aruga A, Kobayashi H, Yamato M, Yamamoto M.
Development of a novel in vivo cancer model using cell sheet engineering
Anticancer Res
2014
34(9):4747-54.
PubMed ID: 25202053
|
|
15817
Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.
A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines
PLoS One
2014
9(2):e90155
PubMed ID: 24587255
DOI: 10.1371/journal.pone.0090155
|
|
15903
Takabayashi K, Kashiwagi K, Kawata T, Sato T, Matsuoka K, Hisamatsu T, Takaishi H, Hibi T, Ogata H, Yahagi N, Kitagawa Y, Shigematsu N, Kanai T.
Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin
Cancer Biol Ther
2014
15(1):81-8
PubMed ID: 24149371
DOI: 10.4161/cbt.26610
|
|
16006
Ramesh V, Ananda Rao B, Sharma P, Swarna B, Thummuri D, Srinivas K, Naidu VG, Jayathirtha Rao V.
Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents
Eur J Med Chem
2014
83:569-80
PubMed ID: 24996143
DOI: 10.1016/j.ejmech.2014.06.013
|
|
16016
Nakamura A, Nakajima G, Okuyama R, Kuramochi H, Kondoh Y, Kanemura T, Takechi T, Yamamoto M, Hayashi K.
Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
Gastric Cancer
2014
17(1):188-95
PubMed ID: 23494117
DOI: 10.1007/s10120-013-0249-7
|
|
16650
Otsuki T, Fujimoto D, Hirono Y, Goi T, Yamaguchi A.
Thrombin conducts epithelial‑mesenchymal transition via protease‑activated receptor‑1 in human gastric cancer
Int J Oncol
2014
45(6):2287-94
PubMed ID: 25231630
DOI: 10.3892/ijo.2014.2651
|
|
17126
Migita K, Takayama T, Matsumoto S, Wakatsuki K, Tanaka T, Ito M, Nishiwada S, Nakajima Y.
Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer
Gastric Cancer
2014
17(4):601-9
PubMed ID: 24292229
DOI: 10.1007/s10120-013-0318-y
|
|
18600
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.
The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion
Int J Oncol
2013
42(2):565-73
PubMed ID: 23242308
DOI: 10.3892/ijo.2012.1738
|
|
19058
Tanaka T, Nakamura J, Kitajima Y, Kai K, Miyake S, Hiraki M, Ide T, Koga Y, Noshiro H.
Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer
Int J Oncol
2013
42(3):894-902
PubMed ID: 23291975
DOI: 10.3892/ijo.2013.1759
|
|
5838
Endo H, Shiroki T, Nakagawa T, Yokoyama M, Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, Iijima K, Shimosegawa T, Sugamura K, Satoh
Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer.
PLoS One
2013
8(10):e77070
PubMed ID: 24130837
DOI: 10.1371/journal.pone.0077070
|
|
5840
Kawada M, Inoue H, Ohba S, Hatano M, Amemiya M, Hayashi C, Usami I, Abe H, Watanabe T, Kinoshita N, Igarashi M, Masuda T, Ikeda D, Nomoto
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.
J Antibiot (Tokyo)
2013
66(9):543-8
PubMed ID: 23632919
DOI: 10.1038/ja.2013.42
|
|
9102
Toshiaki Tsuji, Mikihito Nakamori, Makoto Iwahashi, Masaki Nakamura, Toshiyasu Ojima, Takeshi Iida, Masahiro Katsuda, Keiji Hayata, Yasushi Ino, Tomoki Todo, Hiroki Yamaue
An Armed Oncolytic Herpes Simplex Virus Expressing thrombospondin-1 Has an Enhanced in Vivo Antitumor Effect Against Human Gastric Cancer
Int J Cancer
2013
132 (2), 485-94
PubMed ID: 22729516
DOI: 10.1002/ijc.27681
|
|
15775
Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y, Takahashi R, Nakata W, Sakitani K, Serizawa T, Hikiba Y, Akanuma M, Shibata W, Maeda S, Koike K.
Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis
PLoS One
2013
8(4):e60914
PubMed ID: 23593346
DOI: 10.1371/journal.pone.0060914
|
|
18767
Yamada M, Oeda A, Jung J, Iijima M, Yoshimoto N, Niimi T, Jeong SY, Choi EK, Tanizawa K, Kuroda S.
Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells
J Control Release
2012
160(2):322-9
PubMed ID: 22100387
DOI: 10.1016/j.jconrel.2011.11.004
|
|
5848
Kataoka Y, Mukohara T, Tomioka H, Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M, Minami H.
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
Invest New Drugs
2012
30(4):1352-60
PubMed ID: 21655918
DOI: 10.1007/s10637-011-9699-0
|
|
5850
Miyato H, Tsuno NH, Kitayama J.
Semaphorin 3C is involved in the progression of gastric cancer.
Cancer Sci
2012
103(11):1961-6
PubMed ID: 22924992
DOI: 10.1111/cas.12003
|
|
5852
Tomioka H, Mukohara T, Kataoka Y, Ekyalongo RC, Funakoshi Y, Imai Y, Kiyota N, Fujiwara Y, Minami H.
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Int J Oncol
2012
41(2):551-8
PubMed ID: 22614071
DOI: 10.3892/ijo.2012.1485
|
|
6104
Hiraki M, Kitajima Y, Kai K, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Knockdown of hypoxia-inducible factor-1α accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines.
Exp Ther Med
2012
4(3):355-362
PubMed ID: 23181099
DOI: 10.3892/etm.2012.600
|
|
15746
Hayakawa Y, Hirata Y, Sakitani K, Nakagawa H, Nakata W, Kinoshita H, Takahashi R, Takeda K, Ichijo H, Maeda S, Koike K.
Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer
Cancer Sci
2012
103:2181-5
PubMed ID: 23110662
DOI: 10.1111/cas.12024
|
|
7876
Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Ann. Surg. Oncol.
2011
18:3013-9
PubMed ID: 21409489
DOI: 10.1245/s10434-011-1636-0
|
|
7937
Saito S, Tomida A.
Use of chemical genomics in assessment of the UPR.
Meth. Enzymol.
2011
491:327-41
PubMed ID: 21329808
DOI: 10.1016/B978-0-12-385928-0.00018-3
|
|
7990
Aoki M, Ishigami S, Uenosono Y, Arigami T, Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S, Natsugoe S.
Expression of BMP-7 in human gastric cancer and its clinical significance.
Br. J. Cancer
2011
104:714-8
PubMed ID: 21224856
DOI: 10.1038/sj.bjc.6606075
|
|
8253
Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.
Reduced expression of RAS protein activator like-1 in gastric cancer.
Int. J. Cancer
2011
128:1293-302
PubMed ID: 20473946
DOI: 10.1002/ijc.25459
|
|
5890
Matsunaga T, Saito H, Ikeguchi M.
Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer.
Yonago Acta Med
2011
54(1):1-10
PubMed ID: 24031123
|
|
5866
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.
Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
Am J Pathol
2011
178(2):515-24
PubMed ID: 21281785
DOI: 10.1016/j.ajpath.2010.10.010
|
|
6115
Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.
Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Oncol Rep
2011
26(6):1385-92
PubMed ID: 21894439
DOI: 10.3892/or.2011.1450
|
|
16307
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M.
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
BMC Cancer
2011
11:122
PubMed ID: 21466710
DOI: 10.1186/1471-2407-11-122
|
|
8325
Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H.
Adiponectin receptors are downregulated in human gastric cancer.
J. Gastroenterol.
2010
45:918-27
PubMed ID: 20336470
DOI: 10.1007/s00535-010-0228-2
|
|
8416
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.
HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
Int. J. Cancer
2010
127:1158-71
PubMed ID: 20020496
DOI: 10.1002/ijc.25129
|
|
18967
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.
The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
BMC Cancer
2010
10:443
PubMed ID: 20723226
DOI: 10.1186/1471-2407-10-443
|
|
8520
Kim JC, Shin ES, Kim CW, Roh SA, Cho DH, Na YS, Kim TW, Kim MB, Hyun YL, Ro S, Kim SY, Kim YS.
In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
Anticancer Res.
2009
29:3027-34
PubMed ID: 19661311
|
|
8590
Miyato H, Kitayama J, Yamashita H, Souma D, Asakage M, Yamada J, Nagawa H.
Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.
J. Surg. Res.
2009
155:40-7
PubMed ID: 19394652
DOI: 10.1016/j.jss.2008.06.045
|
|
5031
Ohnuma S, Miura K, Horii A, Fujibuchi W, Kaneko N, Gotoh O, Nagasaki H, Mizoi T, Tsukamoto N, Kobayashi T, Kinouchi M, Okabe M, Sasaki H, Shiiba K, Miyagawa K, Sasaki I.
Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues.
Surgery
2009
145(1):57-68
PubMed ID: 19081476
DOI: 10.1016/j.surg.2008.08.010
|
|
5874
Tu SP, Chi AL, Ai W, Takaishi S, Dubeykovskaya Z, Quante M, Fox JG, Wang TC.
p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells.
Am J Physiol Gastrointest Liver Physiol
2009
297(2):G385-96
PubMed ID: 19541923
DOI: 10.1152/ajpgi.90620.2008
|
|
5876
Takaishi S1, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC.
Identification of gastric cancer stem cells using the cell surface marker CD44.
Stem Cells.
2009
27(5):1006-20
PubMed ID: 19415765
DOI: 10.1002/stem.30
|
|
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.
Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
DOI: 10.1248/bpb.32.1148
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18966
Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T.
Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines
J Surg Res
2008
148(2):197-204
PubMed ID: 18395750
DOI: 10.1016/j.jss.2007.08.014
|
|
5893
Hara M, Nakanishi H, Jun Q, Kanemitsu Y, Ito S, Mochizuki Y, Yamamura Y, Kodera Y, Tatematsu M, Hirai T, Kato T.
Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.
Clin Exp Metastasis
2007
24(3):179-89
PubMed ID: 17487561
DOI: 10.1007/s10585-007-9067-9
|
|
16154
Higashiyama M, Ito T, Tanaka E, Shimada Y.
Prognostic significance of osteopontin expression in human gastric carcinoma
Ann Surg Oncol
2007
14(12):3419-27
PubMed ID: 17896150
DOI: 10.1245/s10434-007-9564-8
|
|
5897
Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M.
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Oncology
2006
70(2):126-33
PubMed ID: 16645325
DOI: 10.1159/000093003
|
|
5899
Yokoyama H, Ikehara Y, Kodera Y, Ikehara S, Yatabe Y, Mochizuki Y, Koike M, Fujiwara M, Nakao A, Tatematsu M, Nakanishi H.
Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis.
Br J Cancer
2006
95(11):1504-13
PubMed ID: 17088902
DOI: 10.1038/sj.bjc.6603459
|
|
5902
Mori A, Asano T, Maruyama T, Ohashi N, Inoue H, Takekoshi S, Okuno M.
Transnasal ERCP/ENBD using an ultrathin esophagogastroduodenoscope.
J Gastroenterol
2006
41(12):1237-8
PubMed ID: 17287905
DOI: 10.1007/s00535-006-1911-1
|
|
3376
Shida, Dai, Kitayama, Joji, Mori, Ken, Watanabe, Toshiaki, Nagawa, Hirokazu
Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells.
Cancer Res
2005
65:9159-63
PubMed ID: 16230373
DOI: 10.1158/0008-5472.CAN-05-0598
|
|
3109
Honjo, Soichiro, Osaki, Mitsuhiko, Ardyanto, Tonang Dwi, Hiramatsu, Toshiki, Maeta, Noritaka, Ito, Hisao
COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
DNA Cell Biol
2005
24:141-7
PubMed ID: 15767780
DOI: 10.1089/dna.2005.24.141
|
|
3167
Horie, Nobuyuki, Hirabayashi, Naomi, Takahashi, Yoshie, Miyauchi, Yuko, Taguchi, Hiroko, Takeishi, Keiichi
Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells.
Biol Pharm Bull
2005
28:574-9
PubMed ID: 15802789
DOI: 10.1248/bpb.28.574
|
|
3375
Ohta M, Tateishi K, Kanai F, Watabe H, Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Ijichi H, Ikenoue T, Sata M, Miyagishi M, Taira K, Tada M, Kawabe T, Omata M.
p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells.
Cancer Res.
2005
65:10822-9
PubMed ID: 16322228
DOI: 10.1158/0008-5472.CAN-05-0777
|
|
5919
Shizue Yoshioka, Shigeru Tatebe, Naruo Tokuyasu, Kenjiro Taniguchi, Yoshimi Ogami, Osamu Yamamoto, Keigo Ashida, Yoshihito Gomyo, Akira Kondo, Shunichi Tsujitani and Masahide Ikeguchi
The PI3K-Akt Pathway in SN-38-Induced Apoptosis in Human Gastric Cancer Cell Lines
Yonago Acta medica
2005
48:7–16
|
|
6449
Yamashita Y, Nishida K, Okuda T, Nomura K, Matsumoto Y, Mitsufuji S, Horiike S, Hata H, Sakakura C, Hagiwara A, Yamagishi H, Taniwaki M.
Recurrent chromosomal rearrangements at bands 8q24 and 11q13 in gastric cancer as detected by multicolor spectral karyotyping.
World J Gastroenterol
2005
11(33):5129-35
PubMed ID: 16127741
DOI: 10.3748/wjg.v11.i33.5129
|
|
12834
Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y.
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori
Mol Biol Cell
2005
16(10):4954-66.
PubMed ID: 16030249
DOI: 10.1091/mbc.e05-05-0426
|
|
2807
Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H
Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Exp Cell Res
2004
301:168-78
PubMed ID: 15530853
DOI: 10.1016/j.yexcr.2004.08.008
|
|
3206
Wen, Xian-Zi, Miyake, Satoshi, Akiyama, Yoshimitsu, Yuasa, Yasuhito
BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells.
Biochem Biophys Res Commun
2004
316:100-6
PubMed ID: 15003517
DOI: 10.1016/j.bbrc.2004.02.016
|
|
3105
Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, Adachi H, Sato K, Oshimura M, Ito H
Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Eur J Clin Invest
2004
34:605-12
PubMed ID: 15379759
DOI: 10.1111/j.1365-2362.2004.01401.x
|
|
5922
Meng H, Lu C, Mabuchi H, Tanigawa N.
Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Cancer Lett
2004
216(2):147-55
PubMed ID: 15533590
DOI: 10.1016/j.canlet.2003.12.020
|
|
5923
Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H.
Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome.
Pharmacol Res.
2004
50(1):65-76
PubMed ID: 15082031
DOI: 10.1016/j.phrs.2003.12.015
|
|
5924
Oyama K, Terashima M, Takagane A, Maesawa C.
Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction.
Br J Surg
2004
91(4):435-43
PubMed ID: 15048743
DOI: 10.1002/bjs.4455
|
|
3103
Adachi, Keiko, Osaki, Mitsuhiko, Kase, Satoru, Takeda, Ami, Ito, Hisao
Anti-Fas antibody-induced apoptosis and its signal transduction in human gastric carcinoma cell lines.
Int J Oncol
2003
23:713-9
PubMed ID: 12888908
|
|
18968
Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T.
Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells
Am J Pathol
2003
163(5):1911-9
PubMed ID: 14578190
DOI: 10.1016/S0002-9440(10)63549-3
|
|
5931
Terashima M, Fujiwara H, Takagane A, Abe K, Irinoda T, Nakaya T, Yonezawa H, Oyama K, Saito K, Kanzaki N, Ohtani S, Nemoto T, Hoshino Y, Kogure M, Gotoh M.
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Gastric Cancer
2003
6 Suppl 1:71-81.
PubMed ID: 12775024
DOI: 10.1007/s10120-003-0221-z
|
|
5932
Fujiwara 1, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T.
Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
Eur J Cancer
2003
39(16):2387-94
PubMed ID: 14556932
DOI: 10.1016/s0959-8049(03)00513-6
|
|
5936
Terashima M, Irinoda T, Kawamura H, Takagane A, Abe K, Oyama K, Fujiwara H, Saito K, Gotoh M, Shirasaka T.
Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
Cancer Chemother Pharmacol
2003
51(3):240-6
PubMed ID: 12655443
DOI: 10.1007/s00280-003-0568-1
|
|
18970
Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ.
Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues
J Pathol
2002
197(5):582-8
PubMed ID: 12210076
DOI: 10.1002/path.1147
|
|
5940
Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama M.
Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.
J Virol
2002
76(13):6825-31
PubMed ID: 12050395
DOI: 10.1128/jvi.76.13.6825-6831.2002
|
|
5941
Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T, Fukushima M.
Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Jpn J Cancer Res
2002
93(12):1342-50
PubMed ID: 12495474
DOI: 10.1111/j.1349-7006.2002.tb01243.x
|
|
5944
Shinohara H, Morita S, Kawai M, Miyamoto A, Sonoda T, Pastan I, Tanigawa N.
Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin.
J Surg Res
2002
102(2):169-77
PubMed ID: 11796015
DOI: 10.1006/jsre.2001.6305
|
|
3772
Ijichi H, Ikenoue T, Kato N, Mitsuno Y, Togo G, Kato J, Kanai F, Shiratori Y, Omata M.
Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
Biochem Biophys Res Commun
2001
289(2):350-7
PubMed ID: 11716479
DOI: 10.1006/bbrc.2001.5988
|
|
5950
Sato K, Sasaki K, Akiyama Y, Yamaguchi K.
Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines.
Cancer Lett
2001
170(2):153-9
PubMed ID: 11463493
DOI: 10.1016/s0304-3835(01)00567-5
|
|
5953
Matsumura M, Ijichi M, Shiratori Y, Togo G, Hikiba Y, Inoued K, Kohara M, Omata M.
Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use.
Hepatol Res
2001
20(1):84-96
PubMed ID: 11282488
DOI: 10.1016/s1386-6346(00)00131-5
|
|
5957
Senoo M, Tsuchiya I, Matsumura Y, Mori T, Saito Y, Kato H, Okamoto T, Habu S.
Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Br J Cancer
2001
84(9):1235-41
PubMed ID: 11336476
DOI: 10.1054/bjoc.2000.1735
|
|
5958
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T, Yamagishi H.
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.
Br J Cancer
2001
84(6):824-31
PubMed ID: 11259099
DOI: 10.1054/bjoc.2000.1684
|
|
15590
Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T, Itoh M.
Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1
Oncogene
2001
20(7):869-73
PubMed ID: 11314020
DOI: 10.1038/sj.onc.1204160
|
|
19063
Bai Y, Akiyama Y, Nagasaki H, Yagi OK, Kikuchi Y, Saito N, Takeshita K, Iwai T, Yuasa Y.
Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines
Mol Carcinog
2000
28(3):184-8
PubMed ID: 10942535
DOI: 10.1002/1098-2744(200007)28:3<184::aid-mc7>3.0.co;2-6
|
|
6160
Jawhari AU, Noda M, Farthing MJ, Pignatelli M.
Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.
Br J Cancer
1999
80(3-4):322-30
PubMed ID: 10408833
DOI: 10.1038/sj.bjc.6690358
|
|
5971
Kataoka H, Joh T, Kasugai K, Okayama N, Moriyama A, Asai K, Kato T.
Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa.
Life Sci
1998
63(7):553-64
PubMed ID: 9718081
DOI: 10.1016/s0024-3205(98)00306-3
|
|
2194
Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R
Analysis of the DPC4 gene in gastric carcinoma
Jpn J Cancer Res
1997
88:335-339
PubMed ID: 9197522
DOI: 10.1111/j.1349-7006.1997.tb00385.x
|
|
5973
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Genes Chromosomes Cancer
1997
20(1):98-102
PubMed ID: 9290961
|
|
2248
Koike N, Todoroki T, Komano H, Shimokama T, Ban S, Ohno T, Fukao K, Watanabe T.
Invasive potentials of gastric carcinoma cell lines: role of alpha 2 and alpha 6 integrins in invasion.
J Cancer Res Clin Oncol
1997
123(6):310-6
PubMed ID: 9222296
DOI: 10.1007/bf01438306
|
Back
Top
CELL BANK Website
